The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bucy, R. P.
Right arrow Articles by Schreiber, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bucy, R. P.
Right arrow Articles by Schreiber, R. D.

The Journal of Immunology, Vol 140, Issue 4 1148-1152, Copyright © 1988 by American Association of Immunologists


ARTICLES

Lack of an obligate role for IFN-gamma in the primary in vitro mixed lymphocyte response

RP Bucy, DW Hanto, E Berens and RD Schreiber
Department of Pathology, Washington University School of Medicine, St. Louis, MO 63110.

We have investigated the relative importance of two lymphokines, IL-2 and IFN-gamma, in the primary murine MLR. Three separate lines of evidence indicate that IL-2 and not IFN-gamma is the relevant lymphokine for both proliferation and activation of CTL in these cultures. No obligate role for IFN-gamma was found. First, CTL activation in the presence of high dose cyclosporin A was partially reconstituted with IL-2, although no detectable IFN-gamma was produced in such cultures. In addition, IFN-gamma could not reconstitute cyclosporin-inhibited cultures. Second, inclusion of a high concentration of several distinct anti-IFN-gamma antibodies failed to inhibit MLR cultures. Third, CTL activation by stimulator cells inactivated by UV irradiation was reconstituted by IL-2, but not by IFN- gamma. These data do not support an autocrine role of IFN-gamma in CTL activation and confirm the importance of IL-2 in the primary murine MLR.


This article has been cited by other articles:


Home page
Cancer Res.Home page
C. Nakajima, Y. Uekusa, M. Iwasaki, N. Yamaguchi, T. Mukai, P. Gao, M. Tomura, S. Ono, T. Tsujimura, H. Fujiwara, et al.
A Role of Interferon-{{gamma}} (IFN-{{gamma}}) in Tumor Immunity: T Cells with the Capacity to Reject Tumor Cells Are Generated But Fail to Migrate to Tumor Sitesin IFN-{{gamma}}-deficient Mice
Cancer Res., April 1, 2001; 61(8): 3399 - 3405.
[Abstract] [Full Text]


Home page
ScienceHome page
D. Dalton, S Pitts-Meek, S Keshav, I. Figari, A Bradley, and T. Stewart
Multiple defects of immune cell function in mice with disrupted interferon-gamma genes
Science, March 19, 1993; 259(5102): 1739 - 1742.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1988 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1988 by The American Association of Immunologists, Inc. All rights reserved.